Aardvark Therapeutics director Zhang Zhongwei files initial beneficial ownership statement
AARD•Director Zhang Zhongwei filed an initial Form 3 on Oct. 8, 2026, covering his holdings in Aardvark Therapeutics.
1. Initial ownership filing
Zhang filed an initial Form 3 covering his holdings in Aardvark Therapeutics on Oct. 8, 2026.
